PHARMADIRECT A/S: Financial statements 2016
CVR: 34221138
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
PHARMADIRECT A/S (CVR 34221138) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -12,216 and a net result of DKK 256,395 compared with DKK -3,621,243 the year before. Equity in the 2016 report amounted to DKK 2,544,379. The solvency ratio was 99.8%.
- Gross Profit
- DKK -12,216
- Profit/Loss
- DKK 256,395
- Equity
- DKK 2,544,379
- Total Assets
- DKK 2,550,654
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | -12 t. | 256 t. | 2.5 mio. | - |
| 2015 | - | -2 mio. | -3.6 mio. | 2.3 mio. | - |
| 2014 | - | -92 t. | -683 t. | 19.8 mio. | - |
| 2013 | - | -40 t. | -40 t. | 442 t. | - |
| 2012 | - | -18 t. | -18 t. | 482 t. | - |
Official annual report
Find more companies like PHARMADIRECT A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
PHARMADIRECT A/S has published its annual report for 2015. Gross profit came to DKK -1,980,512, and the net result was DKK -3,621,243.
About PHARMADIRECT A/S
PHARMADIRECT A/S was a Danish company of the type Aktieselskab based in Køge, founded in 2012. The company has been dissolved on 6 March 2024. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company has 0 employees (2016). In 2022, the company reported a gross profit of DKK -10,000 and a net result of DKK -29,034 compared with DKK -27,431 the year before. Equity in the 2022 report amounted to DKK 2,410,080.